Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)
Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
MDMA (3,4-Methylenedioxymethamphetamine, "Ecstasy") produces tachycardia, hypertension,
hyperthermia, and other acute adverse effects. Ecstasy use has also been associated with rare
cardio- and cerebrovascular complications. The role of beta-blockers in the treatment of
cardiovascular and adverse effects of MDMA is unknown.